Elucidation of pharmacokinetics of anti arrhythmic drugs

Elucidation of pharmacokinetics of carvedilol and flecainide - Elucidation of pharmacokinetics of carvedilol and flecainide

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052353

Enrollment

Registered

2024-01-01

Start date

2024-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension,heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients taking carvedilol and flecainide and for whom lumbar anesthesia is not contraindicated

Exclusion criteria

Exclusion criteria: Patients who cannot consent

Design outcomes

Primary

Measure	Time frame
Correlate the blood concentration of carvedilol and flecainide in the cerebrospinal fluid concentration	—

Countries

Japan

Contacts

Public ContactMirei Kamimura

Juntendo University Urayasu Hospital Clinical Laboratory Medicine

m.kamimura.vo@juntendo.ac.jp047-353-3111

Outcome results